The Food and Drug Administration rattled the biotech industry last week when it said it wouldn’t even look at Moderna’s application to market the first mRNA flu shot. But on Wednesday, the agency reversed course and told Moderna it would review the application with some changes.
Read more from NPR: FDA reverses course on Moderna flu shot
How Did Trump Lose Today? 